Microvesicles/exosomes as potential novel biomarkers of metabolic diseases
Günter MüllerDepartment of Biology 1, Genetics, Ludwig-Maximilians University Munich, Biocenter, Munich, GermanyAbstract: Biomarkers are of tremendous importance for the prediction, diagnosis, and observation of the therapeutic success of common complex multifactorial metab...
Saved in:
Main Author: | Müller G |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2012
|
Subjects: | |
Online Access: | https://doaj.org/article/7f55c13c4cda4cb7b110d2d8103806c5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diet-induced metabolic hamster model of nonalcoholic fatty liver disease
by: Bhathena J, et al.
Published: (2011) -
The association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in Canadian adults
by: Da Costa LA, et al.
Published: (2012) -
Metabolic abnormalities in pituitary adenoma patients: a novel therapeutic target and prognostic factor
by: Zheng X, et al.
Published: (2015) -
Disturbance of inorganic phosphate metabolism in diabetes mellitus: temporary therapeutic intervention trials
by: Jørn Ditzel, et al.
Published: (2009) -
Relationship between chronic kidney disease and metabolic syndrome: current perspectives
by: Nashar K, et al.
Published: (2014)